{
  "parties": [
    "DEXCEL LTD., with its registered address at ****, Israel (\"Dexcel\")",
    "KITOV Pharma Ltd"
  ],
  "effective_date": null,
  "governing_law": null,
  "payment_terms": {
    "text": "Payment Terms 3.6.1 All payments shall be made by bank transfer to such account as may be indicated by Dexcel, Dexcel and Kitov each bearing their own bank transfer costs, net thirty (30) days from Delivery. All payments shall be made in U.S. Dollars. 3.6.2 With the exception of amounts in legitimate dispute, in the event that Kitov is more than twenty one (21) Working Days late in meeting the payment schedule set forth in Section ​3.6.1, Dexcel may, upon seven (7) Working Days' written notice to Kitov (i) delay the delivery of Product ordered until the amounts in arrears are paid, (ii) charge",
    "start": 18247,
    "end": 18847
  },
  "termination_clause": {
    "text": "termination of this Agreement. 1.34 \"Regulatory Authority\" shall mean, in a particular country or jurisdiction, any applicable governmental authority involved in granting a Marketing Authorization in such country or jurisdiction, including, inter alia, the FDA and EMA. 1.35 \"Specifications\" shall mean the pharmacochemical, manufacturing, stability and other specifications of a Product defined in such Product's Marketing Authorization, subject to change from time to time as reasonably required to meet any requirements of the relevant Health Authorities. 1.36 \"Supply Commencement Date\" shall mean the date upon which Dexcel makes the first Delivery of the Product to Kitov pursuant to an Confirmed Order. 1.37 \"Supply Price\" shall have the meaning set forth in Section ​3.4. 1.38 \"Term\" shall have the mean",
    "start": 9741,
    "end": 10552
  },
  "_doc_id": "KitovPharmaLtd_20190326_20-F_EX-4.15_11584449_EX-4.15_Manufacturing Agreement.txt",
  "_char_count": 57436
}